AYOXXA Biosystems GmbH

📍 Cologne, Germany🗓 Founded 2010👥 35 employees💰 Last funded Dec 2018
AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARIS™. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARIS™ is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics by addressing all the needs from basic to clinical research and development. AYOXXA is commercializing and expanding a portfolio of detection kits covering ophthalmology, model-to-man and immuno-oncology applications.
7
Total investors
4
Early stage
2
Mid stage
1
Late stage
2010
Founded
Investor geography3 countries
Germany
5
Singapore
1
France
1
Investor activity2010–2018 · investors recorded per year
2010120123201412015120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in AYOXXA Biosystems GmbH?
AYOXXA Biosystems GmbH has 7 investors on record on gritt.io, including 4 early-stage backers, 2 mid-stage and 1 late-stage investors.
When did AYOXXA Biosystems GmbH last raise funding?
The most recent investment in AYOXXA Biosystems GmbH recorded on gritt.io was in December 2018.
When was AYOXXA Biosystems GmbH founded?
AYOXXA Biosystems GmbH was founded in 2010.
What industry is AYOXXA Biosystems GmbH in?
AYOXXA Biosystems GmbH operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is AYOXXA Biosystems GmbH based?
AYOXXA Biosystems GmbH is headquartered in Cologne, Germany.